Acima Private Wealth’s Avanos Medical AVNS Stock Holding History

Acima Private Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	–	–	264
2018 Q4	$0	Buy	+1	New	+$52	﹤0.01%	293

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acima Private Wealth's AVNS Position: Q1 2019 in Review

Acima Private Wealth sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 1 share.

Acima Private Wealth first reported a position in AVNS in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

Acima Private Wealth reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
Acima Private Wealth sold 1 Avanos Medical share in Q1 2019.
Acima Private Wealth first reported a position in Avanos Medical in Q4 2018 and held it in 1 quarter.
Acima Private Wealth's Avanos Medical position peaked at $0 in Q4 2018.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Acima Private Wealth's 13F filing for Q1 2019, filed 6 May 2019.